EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS017-26197 
Organism
Homo sapiens 
Tissue/cell
CD14+_monocyte 
Coordinate
chr5:53971580-53973430 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF1MA0050.2chr5:53972159-53972180GAAGAGAAACAGAAAACAAAA-6.15
Nkx3-2MA0122.3chr5:53973245-53973258ATTAAGTGGTTTT-7.22
STAT1MA0137.3chr5:53973045-53973056TTTCTAGGAAA+6.14
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_01783chr5:53971565-53972089Aorta
SE_01783chr5:53972146-53973247Aorta
SE_10074chr5:53971510-53973415CD14
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr55397161553971811
chr55397231453972697
Number: 2             
IDChromosomeStartEnd
GH05I054675chr55397161553971811
GH05I054676chr55397183053972697
Enhancer Sequence
CCTATGCTGT ACTAGGAGAG CCTGGGAGAG AACTCTGTTT AGAAATAAAC AAGCCCAGGG 60
ATTGCCATCT ATTTGCCCTG TATTCACTTG GACTTATTTA TCATAGTGCT TTTTCAAACT 120
GTGTTCAAAA CTCCCTGGGG TTTTCCAGAG GTGCTTTAGA GACCCAATTC AACCATGTTG 180
GCCTATTTTG GACAAACAAA GGCTTGAAAA TCACCAGCAT ACCTTTTCAC AGTGTACATG 240
CTCTGTCCGA GGTCCAGTGC TCTTGGTGGT TATTAAAAGT GGATTTGTGT GTGTGTATCA 300
AGACTGCCAC GCACTCTCAG AAGTTCACTC TGTGCCCCCC TTCAAGCCCC TCTTGAAGAC 360
AGGAATCTCT CTATTTCTGG TTGTTCTGCC CCTGCCCTCC CTACCTAAAT CCAGACCCTA 420
CTCAAAAAGG AAAATGGTTT CTCAGCATTC CTCCCCATGT TCATTATCTG GCAGCTCTTC 480
TCTGGAGGTT GGAAAGAATT AATCCATTAT TGTTGTCAAC ACAATCATAA TAAGGCATGA 540
AAATGAAGTG ATGAGATCTT TTTTTCAGTC AAACCTCTTG AAGAGAAACA GAAAACAAAA 600
ACAGCATTTT ATCTTTGACT AGAATGATTA TTTCTCAAAG GAAATAACTT CAGTCCCGTA 660
CTTTGTGGGA GGAAAGGCAC AAGATGTGGA GGATGTCCAG GCACTGTGCC TGGCTCACAG 720
ACATTGTTCA TAAATGTTTG GTTCATAGTT TCTTTCATTC ATTCTATAAA CATAAACTCT 780
GATCTCTAGG AGGAGGATTT TATTTGCCTC TTGAACTATC TCTTGACAAA GCCAAGTCAC 840
CACACAAATG ATGCAGGCAA CTGCCAGCTG GTTTGCAAAT TTCCTGAGTT GCCCAAGTAC 900
AGCACAGTGA GCATGAAAAT CAAAGGCTCT CAAACCTGGA AGGAACCTTT AAAAATGACC 960
CGAGGTCAAT TGCCCAGGAA AATCCCTGCC AAGTGCTGCA AGTTGAGGTT GGAAGTGTCC 1020
AGTCTCTCTG ATGCAGCCAA GTCTGTCTTT GGACAACTCT GTTAGAAGGC TCTTCCTGAT 1080
ATTGAATTGA AATCTATCAC TTCATAGCTT TTCTTTATTC CTCCAATAAA TCCTGTATGA 1140
GAGACCAGGA GGCAGAACAG AATCATTCAA ATCCTCCTTC TTGGCAATCT GTTGAATATT 1200
GGAAGACAGG GGCCAAGTTC TCTGAGTCTT CTTTTCTCCA AGGCCTCTGT CTCCTAATCT 1260
TTCAAACATT TCCATGGGAT AAGATTTTCA AATTATCTTG GTCCTTTTCC CATTAAGAAG 1320
CTTTACTTTT CTACTCTTAA AATAGGCTGC CTAGAATAGA AATAATTCCA TGTGACTTAA 1380
CTAGCGCAGA AAGGAACAGA CTCTGCTAAA TCTGATTTCA GAGACTGCCA CTCACTAGCA 1440
GCGTGGCTTT GGCAAGTTAC TTCCCTTTCT AGGAAACATG GTTTAATATG TAGCCTCAAG 1500
TAAAGTGCCT ACTACAGTGC CTGGCATAAA GGGGTGTCAA TACCTGATAT CTACCTATCA 1560
ATTGCTATTA TTCTTCTGTC AATGCAGTTT CAGGTGGCAC TAGACCTTAA GGTGATAACA 1620
TCACACTATT GACTCCTAGG TTTTACCCAC AAGTAAATTC AGAGTATTAA GTGGTTTTAA 1680
TCCATGGCTC CCCCATCCTT TACTCACATT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT 1740
GTGTGTGCCT AAGCATCAAA ATTTCCATTT ATCTTATAAA ATTGTATTTG TTCAATTCAG 1800
GTCATTGTTT AATGTGAGCA AATTTAATGA ACAAGACTCT ATCTTTTTAT 1850